Adam Hill

Adam Hill is a seasoned professional in the life sciences sector with a robust background in technology and drug discovery. Currently involved with multiple organizations, Adam serves as a General Partner at Formation Venture Engineering and as Chief Technology Officer at Triple Sharp Venture Engineering. Previously, Adam held key leadership roles, including Senior Vice President at HotSpot Therapeutics, Inc. and Vice President at Plexium. Adam's career began at the Schering-Plough Research Institute and included significant positions at Millennium Pharmaceuticals and Novartis. Educational credentials include a D.Phil. in Chemistry and Pharmacology from the University of Oxford, along with postdoctoral studies at the University of Connecticut and Harvard University.